CureSearch for Children's Cancer funds and supportstargeted and innovative children's cancer research with measurableresults, and is the authoritative source of information and resourcesfor all those affected by children's cancer.
Tampa, FL - Nationally recognized employee leasing attorney Michael Miller of Tampa's Kunkel Miller & Hament has been appointed to the Board of Directors of CureSearch for Children's Cancer. CureSearch is a national non-profit which funds children's cancer research, a cause close to Miller's heart as his daughter is a childhood cancer survivor and both he and his wife are adult cancer survivors.
"I was looking for a way to help support the doctors and researchers who are working so hard for families like mine," says Miller. "Without advanced research, I, my wife, and my daughter might not be here today. CureSearch has a 25 year history of supporting important children's cancer research, and is working hard to move findings from the laboratory to the patient using innovative and novel research. I am excited to be part of such work."
Earlier this month, CureSearch announced $5 million in funding to three teams of researchers studying areas critical to achieving breakthroughs in treatments and with the potential to reach patients in early clinical trials within three years. Additionally, through its Clinical Trials Advancement Awards, this year the foundation will award up to $2 million to hospitals across the country enrolling children in clinical trials, and continues to fund 12 Young Investigators, and provide resources and education to families.
Ongoing research is particularly important because cancer remains the leading cause of death by disease in children and 40,000 children undergo cancer treatment each year. Twenty percent of children lose their battle with cancer and of those who survive, 60% experience late effects (often secondary cancers) due to the toxicity of the treatment they receive. CureSearch is working to advance the field and create a lasting impact for kids with cancer by funding research with patient-centric outcomes that not only addresses unmet needs, but also uses innovative and novel approaches to do so.
"We are honored that Mike has joined the Board of Directors," says Laura Thrall, president and CEO of CureSearch. "His personal connection to the cause, as well as his legal and business acumen will be of great value to the organization as we work to raise more dollars to continue funding research so that every child has the future they deserve and the one their parents dream of."
About Michael MillerMichael R. Miller, Esq., is a senior partner in the law firm of Kunkel Miller & Hament, a firm which represents private and public sector employers in a wide variety of employment matters, including court and administrative agency litigation, and counsels employers concerning avoidance of labor law problems. Mr. Miller has been Labor Counsel to the Florida Health Care Association since 1984 and has served as General Counsel to the Florida Association of Professional Employer Organizations since 1986. During this time he has drafted or assisted in drafting all of Florida's professional employer organization legislation. He also works extensively in the employee leasing industry throughout the United States. Mr. Miller, his wife, and daughter are all cancer survivors and have benefited from the types of cancer research that CureSearch funds.
About CureSearchCureSearch for Children's Cancer is a national non-profit foundation whose mission is to fund and support targeted and innovative children's cancer research with measurable results, and is the authoritative source of information and resources for all those affected by children's cancer. CureSearch accelerates the cure by driving innovation, eliminating research barriers, and solving the field's most challenging problems; annually funding clinical trials and scientific research questions that challenge the status quo to push the field closer to a cure. Ultimately, CureSearch is working to change the odds for those children most at risk.
Shelby HammondCommunications Manager Email Shelby(240) 235-2205